NCT02981875 is a NA clinical trial of oculomotor training in Ocular Motility Disorders, sponsored by The Hong Kong Polytechnic University.

Who is sponsoring NCT02981875?

NCT02981875 is sponsored by The Hong Kong Polytechnic University.

What drugs are being tested in NCT02981875?

Interventions in NCT02981875: oculomotor training, placebo.

What condition does NCT02981875 study?

NCT02981875 studies Ocular Motility Disorders.

Is NCT02981875 still recruiting?

NCT02981875 is currently completed. Last updated 4 August 2020.

Last reviewed 2020-08-04 · How we verify

NCT02981875

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oculomotor Training Improves Reading Eye Movement

Completed NA Last updated 4 August 2020

What this trial tests

NA trial testing oculomotor training in Ocular Motility Disorders in 30 participants. Completed in 30 September 2019.

Timeline

1 January 2015

Primary endpoint
30 September 2016

30 September 2019

Quick facts

Lead sponsor	The Hong Kong Polytechnic University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	1 January 2015
Primary completion	30 September 2016
Estimated completion	30 September 2019

Drugs / interventions tested

oculomotor training
placebo

Conditions studied

Ocular Motility Disorders — all drugs for Ocular Motility Disorders →

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 8 to 9, any sex, with Ocular Motility Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children with reading eye movement problems were recruited for this study. The treatment group was provided with oculomotor training for 8 weeks, the control group was given placebo exercises.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

NCT07505732 — Information-providing Chatbot · NA · not yet recruiting
NCT07391449 — Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis · NA · not yet recruiting
NCT07450248 — The Use of Telephone-based ACT for Quitting Alcohol in the Young Population With Hazardous or Harmful Alcohol Use. · NA · not yet recruiting
NCT07273682 — Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors · NA · not yet recruiting
NCT07531082 — Effects of a Salutogenic Strength-based Social Robot-assisted Intervention on the Depressive Symptoms and Sense of Coher · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02981875 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Hong Kong Polytechnic University
Last refreshed: 4 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02981875.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing